BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

826 related articles for article (PubMed ID: 23092444)

  • 1. Multiple interaction regions in the orthosteric ligand binding domain of the α7 neuronal nicotinic acetylcholine receptor.
    Xiao Y; Hammond PS; Mazurov AA; Yohannes D
    J Chem Inf Model; 2012 Nov; 52(11):3064-73. PubMed ID: 23092444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2.7 A structure of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor.
    Brejc K; van Dijk WJ; Smit AB; Sixma TK
    Novartis Found Symp; 2002; 245():22-9; discussion 29-32, 165-8. PubMed ID: 12027010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
    Brejc K; van Dijk WJ; Klaassen RV; Schuurmans M; van Der Oost J; Smit AB; Sixma TK
    Nature; 2001 May; 411(6835):269-76. PubMed ID: 11357122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight in nAChR subtype selectivity from AChBP crystal structures.
    Rucktooa P; Smit AB; Sixma TK
    Biochem Pharmacol; 2009 Oct; 78(7):777-87. PubMed ID: 19576182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docking studies of benzylidene anabaseine interactions with α7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): application to the design of related α7 selective ligands.
    Kombo DC; Mazurov A; Tallapragada K; Hammond PS; Chewning J; Hauser TA; Vasquez-Valdivieso M; Yohannes D; Talley TT; Taylor P; Caldwell WS
    Eur J Med Chem; 2011 Nov; 46(11):5625-35. PubMed ID: 21986237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors.
    Hansen SB; Taylor P
    J Mol Biol; 2007 Jun; 369(4):895-901. PubMed ID: 17481657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study on the use of docking and Bayesian categorization to predict ligand binding to nicotinic acetylcholine receptors (nAChRs) subtypes.
    Kombo DC; Bencherif M
    J Chem Inf Model; 2013 Dec; 53(12):3212-22. PubMed ID: 24328365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholine binding protein (AChBP) as template for hierarchical in silico screening procedures to identify structurally novel ligands for the nicotinic receptors.
    Akdemir A; Rucktooa P; Jongejan A; Elk Rv; Bertrand S; Sixma TK; Bertrand D; Smit AB; Leurs R; de Graaf C; de Esch IJ
    Bioorg Med Chem; 2011 Oct; 19(20):6107-19. PubMed ID: 21920761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational studies of novel carbonyl-containing diazabicyclic ligands interacting with α4β2 nicotinic acetylcholine receptor (nAChR) reveal alternative binding modes.
    Kombo DC; Mazurov AA; Strachan JP; Bencherif M
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5105-13. PubMed ID: 23937977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of alpha-conotoxin binding modes on neuronal nicotinic acetylcholine receptors.
    Dutertre S; Nicke A; Tyndall JD; Lewis RJ
    J Mol Recognit; 2004; 17(4):339-47. PubMed ID: 15227641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An allosteric binding site of the α7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein.
    Delbart F; Brams M; Gruss F; Noppen S; Peigneur S; Boland S; Chaltin P; Brandao-Neto J; von Delft F; Touw WG; Joosten RP; Liekens S; Tytgat J; Ulens C
    J Biol Chem; 2018 Feb; 293(7):2534-2545. PubMed ID: 29237730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors.
    Tsetlin V; Utkin Y; Kasheverov I
    Biochem Pharmacol; 2009 Oct; 78(7):720-31. PubMed ID: 19501053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking to flexible nicotinic acetylcholine receptors: a validation study using the acetylcholine binding protein.
    Sander T; Bruun AT; Balle T
    J Mol Graph Model; 2010 Nov; 29(3):415-24. PubMed ID: 20884263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface plasmon resonance biosensor based fragment screening using acetylcholine binding protein identifies ligand efficiency hot spots (LE hot spots) by deconstruction of nicotinic acetylcholine receptor α7 ligands.
    de Kloe GE; Retra K; Geitmann M; Källblad P; Nahar T; van Elk R; Smit AB; van Muijlwijk-Koezen JE; Leurs R; Irth H; Danielson UH; de Esch IJ
    J Med Chem; 2010 Oct; 53(19):7192-201. PubMed ID: 20828128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A computational study of the binding of 3-(arylidene) anabaseines to two major brain nicotinic acetylcholine receptors and to the acetylcholine binding protein.
    Slavov SH; Radzvilovits M; LeFrancois S; Stoyanova-Slavova IB; Soti F; Kem WR; Katritzky AR
    Eur J Med Chem; 2010 Jun; 45(6):2433-46. PubMed ID: 20236734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docking of 6-chloropyridazin-3-yl derivatives active on nicotinic acetylcholine receptors into molluscan acetylcholine binding protein (AChBP).
    Artali R; Bombieri G; Meneghetti F
    Farmaco; 2005 Apr; 60(4):313-20. PubMed ID: 15848206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model of the extracellular domain of the human alpha7 nAChR based on the crystal structure of the mouse alpha1 nAChR extracellular domain.
    Konstantakaki M; Tzartos SJ; Poulas K; Eliopoulos E
    J Mol Graph Model; 2008 Jun; 26(8):1333-7. PubMed ID: 18329305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer modeling of binding of diverse weak toxins to nicotinic acetylcholine receptors.
    Mordvitsev DY; Polyak YL; Kuzmin DA; Levtsova OV; Tourleigh YV; Utkin YN; Shaitan KV; Tsetlin VI
    Comput Biol Chem; 2007 Apr; 31(2):72-81. PubMed ID: 17392029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico characterization of cytisinoids docked into an acetylcholine binding protein.
    Abin-Carriquiry JA; Zunini MP; Cassels BK; Wonnacott S; Dajas F
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3683-7. PubMed ID: 20493692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of agonist and antagonist-bound acetylcholine-binding protein from Aplysia californica.
    Hansen SB; Sulzenbacher G; Huxford T; Marchot P; Bourne Y; Taylor P
    J Mol Neurosci; 2006; 30(1-2):101-2. PubMed ID: 17192647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.